2004
DOI: 10.1107/s1600536804005896
|View full text |Cite
|
Sign up to set email alerts
|

α-{3-[2-(Dimethylammonio)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide succinate (sumatriptan succinate)

Abstract: Key indicatorsSingle-crystal X-ray study T = 293 K Mean '(C±C) = 0.004 A Ê R factor = 0.064 wR factor = 0.158 Data-to-parameter ratio = 16.6For details of how these key indicators were automatically derived from the article, see

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 6 publications
1
11
0
Order By: Relevance
“…In all essential details, the molecular geometry (Table 1) is in good agreement with that of sumatriptan succinate (Ravikumar et al, 2004). The O S O angle is widened from the regular tetrahedral value.…”
Section: Commentsupporting
confidence: 58%
See 1 more Smart Citation
“…In all essential details, the molecular geometry (Table 1) is in good agreement with that of sumatriptan succinate (Ravikumar et al, 2004). The O S O angle is widened from the regular tetrahedral value.…”
Section: Commentsupporting
confidence: 58%
“…The biological and pharmacological aspects of sumatriptan have been studied extensively (Evers et al, 2003;Dahlof, 2003;Diener, 2003). Recently, the crystal structure of sumatriptan succinate (Ravikumar et al, 2004) was published from our laboratory. The present report provides, for the first time, a precise structure determination of this pharmaceutically important compound in its parent form, (I) ( Fig.…”
Section: Commentmentioning
confidence: 99%
“…Viewing the structural features in the light of the theoretical 5-HT 1B -like receptor model (Moloney et al, 1999), the N1Á Á ÁN2 distances are 5.603 (2), 5.564 (4)/4.682 (4) and 5.566 (3)/4.660 (3) Å for (I), (II) and (III), respectively. The corresponding distance is 5.998 (3) Å in sumatriptan succinate (Ravikumar et al, 2004) (Ravikumar et al, 2008b) and 6.322 (2) Å in naratriptan hydrochloride (Ravikumar et al, 2008b).…”
Section: Figurementioning
confidence: 99%
“…Frovatriptan is currently marketed as the monosuccinate salt monohydrate, Frova, by Vernalis partner Endo Pharmaceuticals Inc., USA. In continuation of our crystallographic studies on triptans (Ravikumar et al, 2004(Ravikumar et al, , 2006(Ravikumar et al, , 2007a(Ravikumar et al, ,b, 2008a, we describe herein the crystal structures of frovatriptan with acetic acid, (I), and succinic acid, (II) and (III).…”
Section: Commentmentioning
confidence: 99%
“…Eletriptan and naratriptan, the second-generation drugs of Pfizer and Glaxo Wellcome, respectively, are more lipophilic and have higher oral bioavailability than sumatriptan (Tepper et al, 2002). We have been studying the structural characteristics of a series of triptans (Ravikumar et al, 2004(Ravikumar et al, , 2006(Ravikumar et al, , 2007a(Ravikumar et al, ,b, 2008, and the present study of eletriptan hydrobromide monohydrate, (I), and naratriptan hydrochloride, (II), is a continuation of our investigation into the threedimensional structural correlation of triptans.…”
Section: Commentmentioning
confidence: 99%